Table 1. Baseline clinicopathologic characteristics of 70 mCRPC patients.
| Characteristics | Median (Range) |
|---|---|
| Age, years | 70 (55-85) |
| PSA, ng/ml | 24.2 (2.6-269.6) |
| Hemoglobin, g/l | 124 (69-156) |
| ALP, U/l | 111 (47-2779) |
| LDH, U/l | 208 (114-2467) |
| ALB, g/l | 44.5 (32.3-52.2) |
| ECOG performance status, No. (%) | |
| 0-1 | 63 (90.0) |
| ≥2 | 7 (10.0) |
| Gleason score of primary lesion, No. (%) | |
| 5-7 | 30 (42.9) |
| 8-10 | 40 (57.1) |
| Site of metastatic disease1, No. (%) | |
| Bone | 65 (92.9) |
| Lymph node | 24 (34.3) |
| Liver | 5 (7.1) |
| Lung | 4 (5.7) |
| Other soft tissue | 5 (7.1) |
PSA, prostate specific antigen; ALP, alkaline phosphatase; LDH, lactate dehydrogenase; ALB, albumin; ECOG, Eastern Cooperative Oncology Group.
1
22 patients developed multi-organ metastasis.